Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder

Completed · Phase 3

Conditions studied: Schizophrenia, Bipolar I Disorder

In brief

The purpose of this study is to demonstrate the efficacy and safety of quetiapine fumarate (SEROQUEL) in the treatment of adolescent patients with schizophrenia and bipolar I disorder.

Key facts

Study ID

NCT00227305

Run by

AstraZeneca

People needed

381

Starts

2004-08-01

Expected to finish

2007-12-01

Last updated by the study team

2013-01-08

Who can join

Age: 10 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient is able to provide written assent and the parents or legal guardian of the patient are/is able to provide written informed consent before beginning any study related procedures
• Patient previously enrolled in either double-blind Study D1441C00149 or D1441C00112
• Patient has documented clinical diagnosis of schizophrenia or bipolar I disorder
• Patient's parent or legal guardian will be able to accompany the patient to each scheduled study visit

You may not qualify if…

• Patients (female) must not be pregnant or lactating
• Patients with a known intolerance or lack of response to previous treatment with quetiapine
• Patients who have previously participated in this study

Where it is running

• Research Site — Dothan, Alabama, United States
• Research Site — Scottsdale, Arizona, United States
• Research Site — Cerritos, California, United States
• Research Site — Riverside, California, United States
• Research Site — Sacramento, California, United States
• Research Site — San Diego, California, United States
• Research Site — Denver, Colorado, United States
• Research Site — Altamonte Springs, Florida, United States
• Research Site — Jacksonville, Florida, United States
• Research Site — Miami, Florida, United States
• Research Site — Chicago, Illinois, United States
• Research Site — Oak Brook, Illinois, United States
• Research Site — Newton, Kansas, United States
• Research Site — Overland Park, Kansas, United States
• Research Site — New Orleans, Louisiana, United States
• Research Site — Las Vegas, Nevada, United States
• Research Site — Rochester, New York, United States
• Research Site — Cincinnati, Ohio, United States
• Research Site — Cleveland, Ohio, United States
• Research Site — Lyndhurst, Ohio, United States
• Research Site — Oklahoma City, Oklahoma, United States
• Research Site — Philadelphia, Pennsylvania, United States
• Research Site — Memphis, Tennessee, United States
• Research Site — Austin, Texas, United States
• Research Site — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.